logo
Origins Launches in the U.S. Amazon Premium Beauty Store

Origins Launches in the U.S. Amazon Premium Beauty Store

Business Wire16-05-2025

NEW YORK--(BUSINESS WIRE)--Origins, with over 30 years of expertise in combining naturally-derived and scientifically crafted ingredients for powerful skincare, announced its official debut in the U.S. Amazon Premium Beauty store today. Origins will offer its iconic skincare and body care products along with giftable sets that are perfect for any occasion. Origins will now bring naturally-derived, effective beauty to Amazon customers nationwide with convenience and thoughtful gifting in mind.
This launch marks a strategic step in Origins' ongoing efforts to meet the evolving needs of skincare shoppers, seeking high-performance, conscious beauty on their favorite platforms. By expanding to the U.S. Amazon Premium Beauty store, Origins reinforces its commitment to delivering both efficacy and accessibility to even more consumers. Amazon customers will now be able to discover and purchase Origins' best-selling products, including the energizing GinZing™ Brightening Eye Cream, the refreshing Checks and Balances™ Frothy Face Wash, and the soothing Mega-Mushroom™ Relief & Resilience Soothing Treatment Lotion. Customers can also explore a wide selection of gifts and skincare and body care favorites, making it easier than ever to share Origins' most loved products for any occasion—from birthdays to holidays to self-care moments.
As part of its commitment to responsible beauty, Origins has recently updated its packaging sustainability across its entire portfolio, including an ongoing mission to improve the sustainability of every jar, tube and bottle. More information about Origins' sustainability efforts can be found at origins.com/sustainable-packaging.
'Today's consumers seek brands that reflect their values and deliver exceptional quality,' said Francesca Damato, Vice President, Global Marketing at Origins. 'For us, that means high-performance skincare powered by nature & science and indulgent, sensorial body care – always with the well-being of people and the planet in mind. Launching in the U.S. Amazon Premium Beauty store allows us to connect with an even broader audience on a platform they know and trust, while also offering a more seamless and convenient gifting experience through Amazon's ready-to-give options.'
With this debut, Origins joins The Estée Lauder Companies' growing portfolio of prestige beauty brands available in the U.S. Amazon Premium Beauty store, further supporting its mission to meet beauty enthusiasts where they are—digitally, conveniently and authentically.
Explore the Origins storefront on Amazon at amazon.com/origins.
For more information, please visit www.origins.com or follow @origins on social media.
About Origins
For over 30 years, Origins has celebrated the genius of nature to create high-performance skincare and body care. We blend nature's most potent ingredients with advanced scientific research and expertise to deliver transformative, deeply sensorial, 100% vegan formulas. Founded with a vision to prioritize the well-being of people and planet, Origins remains committed to responsible sourcing and environmental sustainability and continues to be trusted by consumers globally for skincare that delivers real results.
About The Estée Lauder Companies
The Estée Lauder Companies Inc. (ELC) is one of the world's leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company's products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.
ELC-B

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders

Yahoo

time43 minutes ago

  • Yahoo

Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders

TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced the results of its Annual Meeting of shareholders (the "Shareholders") held yesterday on June 5, 2025 (the "Meeting"). The Company confirms that all resolutions put forward in the Management Information Circular dated April 17, 2025 (the "Circular") to its Shareholders were approved. Results of the matters voted on at the Meeting are set out below. Election of Directors Spectral's seven director nominees were elected: Nominee Votes For (percent) Votes Withheld (percent) Jan D'Alvise 99.78% 0.22% Jun Hayakawa 99.79% 0.21% Chris Seto 89.39% 10.61% William Stevens 99.50% 0.50% Paul Walker 97.67% 2.33% David W. Feigal, Jr. 99.67% 0.33% Cristiano Franzi 99.78% 0.22% Appointment of Auditors MNP LLP, Chartered Accountants, was re-appointed as auditor of Spectral. Votes For: 99.95% Votes Withheld: 0.05% About Spectral Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin™ ('PMX'). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company's FDA cleared Endotoxin Activity Assay (EAA™), the clinically available test for endotoxin in blood. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively over 360,000 times to date. In March 2009, Spectral obtained the exclusive development and commercial rights in the U.S. for PMX, and in November 2010, signed an exclusive distribution agreement for this product in Canada. In July 2022, the U.S. FDA granted Breakthrough Device Designation for PMX for the treatment of endotoxic septic shock. Approximately 330,000 patients are diagnosed with septic shock in North America each year. The Tigris Trial is a confirmatory study of PMX in addition to standard care vs standard care alone and is designed as a 2:1 randomized trial of 150 patients using Bayesian statistics. Endotoxic septic shock is a malignant form of sepsis The trial methods are detailed in 'Bayesian methods: a potential path forward for sepsis trials'. Spectral is listed on the Toronto Stock Exchange under the symbol EDT. For more information, please visit statement Information in this news release that is not current or historical factual information may constitute forward-looking information within the meaning of securities laws. Implicit in this information, particularly in respect of the future outlook of Spectral and anticipated events or results, are assumptions based on beliefs of Spectral's senior management as well as information currently available to it. While these assumptions were considered reasonable by Spectral at the time of preparation, they may prove to be incorrect. Readers are cautioned that actual results are subject to a number of risks and uncertainties, including the company's ability to raise capital and the availability of funds and resources to pursue R&D projects, the recruitment of additional clinical trial sites, the rate of patient enrollment, the successful and timely completion of clinical studies, the success of Baxter's commercialization efforts, the ability of Spectral to take advantage of business opportunities in the biomedical industry, the granting of necessary approvals by regulatory authorities as well as general economic, market and business conditions, and could differ materially from what is currently expected. The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this statement. For further information, please contact: Ali MahdaviCapital Markets & Investor RelationsSpinnaker Capital Markets Inc.416-962-3300am@

Workday Unveils AI Developer Toolset, Empowering Developers to Customize and Connect AI Apps and Agents on the Workday Platform
Workday Unveils AI Developer Toolset, Empowering Developers to Customize and Connect AI Apps and Agents on the Workday Platform

Yahoo

timean hour ago

  • Yahoo

Workday Unveils AI Developer Toolset, Empowering Developers to Customize and Connect AI Apps and Agents on the Workday Platform

New Agent Gateway to Help Developers Accelerate Agentic AI Innovation Across the Enterprise Workday Brings the Power of Illuminate™ into the Development Process, Ushering in New Levels of Productivity and Driving AI-Powered Experiences LAS VEGAS, June 3, 2025 /PRNewswire/ -- Workday DevCon 2025 – Workday, Inc. (NASDAQ: WDAY), the AI platform for managing people, money, and agents, today announced a new unified, AI developer toolset to bring the power of Workday Illuminate directly into the hands of customer and partner developers, enabling them to easily customize and connect AI apps and agents on the Workday platform. Announced at Workday DevCon 2025, the company's annual developer conference, the toolset includes: Agent Gateway. Developers will be able to connect third-party agents to the Workday Agent System of Record (ASOR) to enable seamless agent registration and agent-to-agent collaboration. Partners will also be able to enroll in Workday's new Agent Partner Network and list their agents on the Workday Marketplace. This will enable customers to select and use the right agents for their specific needs while having a unified, trusted way to manage their human and digital workforce. AI Widgets. Developers will be able to add AI-powered widgets into apps and define custom prompts, providing users with personalized AI assistance to create and refine content quickly across HR and finance use cases. For example, AI widgets can help with customer support, automate answers to common questions, or guide users through tasks. Expanded AI Gateway APIs. Developers will be able to integrate new Workday AI services natively into apps, enabling users to ask questions about reports and understand documents using natural language. For example, a developer could leverage document intelligence to automatically classify documents and extract key information. "Today, developers are under immense pressure to rapidly deliver sophisticated AI apps while navigating a complex and fragmented AI landscape. They're piecing together disparate tools and services, hindering their ability to innovate," said Matthew Grippo, senior vice president, core software, Workday. "Workday's new AI developer toolset removes these barriers by empowering developers to seamlessly integrate powerful AI capabilities into the apps and agents that will define the future of work." Turbocharging Productivity with AI Developer Copilot Workday is also expanding Developer Copilot, the conversational AI companion that helps developers code faster, across Workday Extend. Developer Copilot has been shown to increase developer productivity by more than 50% and, now, Workday developers will be able to: Generate App Code Snippets and Data Queries. Chat with Developer Copilot to generate code or data queries, then easily embed these suggestions into apps. Find the Right APIs. Prompt to receive high-context recommendations on the best API for a particular use case, along with examples to get started quickly. Generate and Document Orchestrations. Quickly generate functional orchestrations, then prompt to summarize the orchestration behavior to produce always-up-to-date documentation. Workday is also introducing a new command-line interface (CLI) tool called Workday Developer CLI. This will help developers automate development tasks, collaborate more effectively, and integrate Workday into their DevOps workflows. Workday Illuminate: AI to Power the Future of Work Built on the largest and cleanest HR and financial dataset – fueled by more than 1 trillion transactions a year – Illuminate understands the business context around the data to transform business operations by elevating humans, accelerating finance, and managing an organization's entire fleet of AI agents. From skills to performance, goals, cost and ROI metrics, organizational models, and individual identities, Illuminate has deep contextual understanding of how work gets done. AvailabilityAgent Gateway will be available to early adopter customers by the end of 2025. New Workday AI Services, AI Widgets, new Developer Copilot capabilities (available with Workday Extend Professional), and Workday Developer CLI will be generally available by the end of 2025. For More Information Read about the new Workday Agent Partner Network. Explore new agents from Workday and partners available today on Workday Marketplace. About WorkdayWorkday is the AI platform for managing people, money, and agents. The Workday platform is built with AI at the core to help customers elevate people, supercharge work, and move their business forever forward. Workday is used by more than 11,000 organizations around the world and across industries – from medium-sized businesses to more than 60% of the Fortune 500. For more information about Workday, visit © 2025 Workday, Inc. All rights reserved. Workday and the Workday logo are registered trademarks of Workday, Inc. All other brand and product names are trademarks or registered trademarks of their respective holders. Forward-Looking StatementsThis press release contains forward-looking statements including, among other things, statements regarding Workday's plans, beliefs, and expectations. These forward-looking statements are based only on currently available information and our current beliefs, expectations, and assumptions. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties, assumptions, and changes in circumstances that are difficult to predict and many of which are outside of our control. If the risks materialize, assumptions prove incorrect, or we experience unexpected changes in circumstances, actual results could differ materially from the results implied by these forward-looking statements, and therefore you should not rely on any forward-looking statements. Risks include, but are not limited to, risks described in our filings with the Securities and Exchange Commission ("SEC"), including our most recent report on Form 10-Q or Form 10-K and other reports that we have filed and will file with the SEC from time to time, which could cause actual results to vary from expectations. Workday assumes no obligation to, and does not currently intend to, update any such forward-looking statements after the date of this release, except as required by law. Any unreleased services, features, or functions referenced in this document, our website, or other press releases or public statements that are not currently available are subject to change at Workday's discretion and may not be delivered as planned or at all. Customers who purchase Workday services should make their purchase decisions based upon services, features, and functions that are currently available. View original content to download multimedia: SOURCE Workday Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store